Clinical trial
Clinical Study of Cord Blood MNCs in the Treatment of Bone Marrow Failure After Chemotherapy in Children With Malignant Diseases
NCT05628272 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Cord Blood MNCs in the Treatment of Bone Marrow Failure After Chemotherapy in Children With Malignant Diseases
- Lead sponsor
- Qianfoshan Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 1, 2022
- Completion date
- September 1, 2024
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cord